Adenosine, an important regulator of many cardiac functions, is produced by ectosolic and cytosolic 5 '-nucleotidase. The activity of these enzymes is influenced by several ischemia-sensitive metabolic factors, e.g., ATP, ADP, H+, and inorganic phosphate. However, there is no clear evidence that adenosine itself affects 5'-nucleotidase activity. This study tested whether adenosine decreases the activity of ectosolic and cytosolic 5 '-nucleotidase. Cardiomyocytes were isolated from adult male Wistar rats and suspended in the modified Hepes-Tyrode buffer solution. After stabilization, isolated cardiomyocytes were incubated with and without adenosine (10-9-i0-' M). .05] at 10-6 M adenosine) after 30 min. The decrease in ectosolic and cytosolic 5 '-nucleotidase activity was inhibited by 8-phenyltheophylline and pertussis toxin, and was mimicked by N6-cyclohexyladenosine, an adenosine Al receptor agonist. Neither CGS21680C, and A2 receptor agonist, nor cycloheximide deactivated ectosolic and cytosolic 5 '-nucleotidase. Thus, we conclude that activation of adenosine A1 receptors is coupled to G; proteins and attenuates ectosolic and cytosolic 5 '-nucleotidase activity in rat cardiomyocytes.
Introduction
Adenosine has been reported to modify several key cellular processes in a variety of tissues and organs (1) (2) (3) . Adenosine relaxes vascular smooth muscles (4), inhibits platelet aggregation (5, 6 ) and generation of oxygen-derived free radicals from polymorphonuclear leukocytes (7, 8) , and attenuates increases in myocardial contractility (9, 10) and the release of norepi-nephrine from the presynaptic vesicles (11, 12) . Adenosine is released from cardiomyocytes, coronary endothelial and smooth muscles, and leukocytes in the heart (2, 3). Of immediate concern is the fact that adenosine is released from cardiomyocytes during ischemia and hypoxia via activation of 5 '-nucleotidase, and this enzyme is known to be modulated by ischemia-sensitive metabolic factors, e.g., ATP, ADP, H +, and inorganic phosphate. Since adenosine is produced by ectosolic and cytosolic 5 '-nucleotidase located in the cytoplasm and cellular membrane (2, 3) , released adenosine may affect ectosolic and cytosolic 5 '-nucleotidase activity. However, no clear consensus exists as to whether adenosine decreases or increases ectosolic and cytosolic 5 '-nucleotidase activity. To study whether adenosine modulates 5 '-nucleotidase activity, we measured both ectosolic and cytosolic 5 '-nucleotidase activity with and without exposure to exogenous adenosine. We also investigated whether a decrease in 5 '-nucleotidase activity is receptor mediated using 8-phenyltheophylline and pertussis toxin.
Methods
Materials Adenosine, N6-cyclohexyadenosine (CHA)', pertussis toxin, 8-phenyltheophylline, and alpha, beta-methyleneadenosine 5 
Preparation of cardiomyocytes
Cardiomyocytes were from 97 adult male Wistar rats (200-250 g), as described previously (13) . Briefly, the rats were injected with heparin (600 U, i.p.) 30 min before administration of pentobarbital (0.2 mg/g body wt, i.p.). The hearts were removed quickly and perfused in a Langendorff perfusion apparatus, initially with 25 ml of Ca2 -free modified Hepes-Tyrode buffer solution (NaCl 120 mM, KCI 5 mM, MgSO4 1.2 mM, NaHCO3 5 mM, glucose 10 mM, Hepes 20 mM) equilibrated with 95% 02 and 5% CO2 at 37°C, and then with a digestive solution (Ca2+-free solution containing 0.06% (wt/wt) crude collagenase and 0.1% fatty acid-free bovine albumin) for 30 min. The ventricle was removed and finely minced with scissors in a Ca2+-containing HepesTyrode solution (CaCl2, 1 mM). Cardiomyocytes were dispersed mechanically by gentle pipetting, filtered through gauze, and suspended in the Ca2+-containing solution. Cells were washed twice with Ca2+-containing solution, and the isolated cells were collected by centrifugation (50 g, 1 min) and resuspended in the Ca2+-containing solution (pH 7.3). Microscopic examination demonstrated that almost all of the isolated cells were cardiomyocytes (2% of the cellular components appeared to be fibroblasts), and that 84±5% of the isolated cardiomyocytes were morphologically (rod-shaped) and metabolically (trypan blue exclusion test) intact.
Some cardiomyocytes were treated with pertussis toxin (10 ng/ml) for 18 h at 37°C (14) . Pertussis toxin was activated by incubation at 37°C for 10 min with 10 mM DTT in 100 mM Tris (pH 8.0) and 1 mM EDTA. Viability of cardiomyocytes was not affected by incubation with pertussis toxin. As a control for the pertussis toxin treatment, rat cardiomyocytes were incubated for 18 h without pertussis toxin. Furthermore, we incubated rat cardiomyocytes 18 h with and without cycloheximide. We observed that 80±6% of the incubated isolated cardiomyocytes, with and without pertussis toxin and cycloheximide, were intact.
Experimental protocols
Protocol I. Effects of exogenous adenosine on ectosolic and cytosolic 5 '-nucleotidase activity ofrat cardiomyocytes. We added 10-6 M adenosine to a solution (3 ml) containing 1.0-2.0 x 10' cells, and observed the temporal changes in ectosolic and cytosolic 5 '-nucleotidase activity (n = 5). Next, we varied the dose of adenosine from10-9 to I0-' M to determine the dose-response relationship for exogenous adenosine and 5 '-nucleotidase activity (n = 5 in each dose). Ectosolic and cytosolic 5'-nucleotidase activity was measured 15 min after an exposure to each dose of adenosine because it took 15 min to reach a steady state (Fig. 1) . We also observed the temporal changes in the adenosine concentration of the solution containing cardiomyocytes after addition of 10-6 M adenosine, and the adenosine concentration of the solution 15 min after the exposure to each dose of adenosine (10-9- 
Protocol II. Role of adenosine A1 receptor activation on ectosolic and cytosolic 5'-nucleotidase activity in rat cardiomyocytes. We determined the dose-response relationship between l0-9 and 10-4 M exogenous adenosine and 5 '-nucleotidase activity with concomitant exposures to 8-phenyl-theophylline (10-5 M, n = 5 in each dose of adenosine), pertussis toxin (10 ng/ml, n = 5 in each dose of adenosine), and cycloheximide (0.2 x 10-6 g/ml, n = 5 in each dose of adenosine). We also measured ectosolic and cytosolic 5'-nucleotidase activity 15 min after an exposure to each dose of adenosine during concomitant treatment with pertussis toxin. To confirm the effect of pertussis toxin on Gi proteins in rat cardiomyocytes, we measured cyclic AMP contents before and 15 min after exposure to lo-and 10-6 M isoproterenol with and without adenosine (10-6 M) . If Gi protein is deactivated by pertussis toxin, adenosine can not attenuate the increases in cyclic AMP content of cardiomyocytes. Second, we added 10-6 M CHA to a solution containing 1.0-2.0 x 1i0 rat cardiomyocytes. We observed the temporal changes in the ectosolic and cytosolic 5 '-nucleotidase activity after an exposure to CHA 10-6 M (n = 5). We determined the dose-response relationship between CHA (10-91-0-4 M) and ectosolic and cytosolic 
Adenosine and cyclic AMP measurements
To measure temporal changes in adenosine release from cardiomyocytes ( 15, 16) , we obtained the medium of the suspension of cardiomyocytes by centrifugation with 50 g for 1 min. We added 10 mM EDTA, and 10% TCA in the medium to inhibit degradation of adenosine and 5'-AMP. TCA was removed by water-saturated ether. After centrifugation ( 1,000 g), the supernatant was collected and the adenosine content was determined by radioimmunoassay. 20-min incubation, the mixture was kept in a cold incubation, and was diluted with 100 01 of adenosine 2', 3 '-O-disuccinyl-3-["1251-iodotyrosine methyl ester (0.5 pmol), and 100 t1 of diluted antiadenosine serum. The mixture was kept in a cold water (4°C) bath for 18 h, and the second antibody solution (500,ul goat anti-rabbit immunoglobulin G antiserum) was added. After incubation at 40C for 1 h, the unreacted materials were removed by centrifugation at 2,500 g at 4°C
for 20 min. The radioactivity remaining in the tube was counted using a gamma counter. Since it was possible that unidentified products of adenosine metabolism or the substrates other than adenosine in the supernatant interfere with the immunoassay of adenosine, we tested to see if immunoreactive adenosine can be removed by incubation with adenosine deaminase (10 U/ml). Measured adenosine concentration in the supernatant was decreased to 5±3%, indicating that this assay technique provides the adenosine concentration with high specificity. The method of the measurement of cyclic AMP concentration in tissues has been previously described (17) . After exposures to adenosine and isoproterenol with and without pertussis toxin treatment, cardiomyocytes were frozen in liquid nitrogen, and immediately stored at -800C in liquid nitrogen. The frozen tissue was powdered, and homogenized at 4°C in 1 ml of ice-cold 10% TCA, centrifuged at 2,500 g for 20 min.
The supematant fluid was removed and extracted three times with 3 ml of diethyl ether saturated with water, and stored in the freezer (-80°C).
The cyclic AMP concentration in the supematant fluid was measured by the radioimmunoassay method (17) . Briefly, 100 tl of dioxanetriethylamine mixture containing succinic acid anhydride succinylated cyclic AMP in the supernatant (100 Al). After a 10-min incubation, the reaction mixture was added to 800 jil of 0.3 M imidazole buffer (pH 6.5). 100 ,ld of succinyl cyclic AMP tyrosine methyl ester iodinated with 1251 (15, ,000 cpm in an amount < 10-14 M) was added to the assay mixture containing 100 ILI of the supernatant and 100 JAI of diluted antisera in the presence of chloramine T; the mixture was kept 
Immunoblotting of ectosolic 5'-nucleotidase
The supernatants obtained for the measurement of ectosolic 5 '-nucleotidase activity were used for the immunoblotting of ectosolic 5 '-nucleotidase. The proteins of the supematants were separated on 10% SDS-PAGE. After electrophoresis, proteins were transferred to polyvinyldifluoride (Millipore, Bedford, MA) for immunoblotting with anti-ectosolic 5'-nucleotidase antibody (rabbit serum, 1/ 1,000 dilution), and subsequently revealed by alkaline phosphatase-conjugated goat antirabbit IgG as a secondary antibody (1 /3,000 dilution, Bio-Rad Laboratories, Richmond, CA) using 5% powdered skim milk in TBS as a blocking agent. Alkaline phosphatase activity was detected using bromochloroindolyl phosphate/nitro blue tetrazolium as a substrate.
Statistical analysis
Statistical analysis was performed using paired and unpaired t tests (19) . Repeated measures of ANOVA followed by modified Bonferonni's multiple comparison were also performed to evaluate differences in the time course and dose-response curve between the two groups. All values were expressed as means±SEM; P < 0.05 was considered significant.
Results
Ectosolic 5'-nucleotidase activity in rat cardiomyocytes decreased from 20.6±2.3 to 8.6±1.6 ,mol/min per 106 cells after 30 min of exposure to exogenous adenosine 10-6 M: It began to decrease within 5 min after exposure to adenosine, and thereafter became stable at 15 min (Fig. IA) . Cytosolic 5 '-nucleotidase activity was also decreased by exposure to adenosine 10-6 M (Fig. 1 B) . Increased concentrations of exogenous adenosine decreased both ectosolic and cytosolic 5 '-nucleotidase activity (Fig. 2) . Table I shows the adenosine concentrations of the solution containing rat cardiomyocytes after 15 min of exposure to each dose of exogenous adenosine. The degradation and uptake of the added adenosine were less than 5% for 15 min in each dose of adenosine.
We next investigated whether the decreases in ectosolic and cytosolic 5'-nucleotidase activity were adenosine Al receptor mediated. First, 8-phenyltheophylline blunted the decreases in ectosolic and cytosolic 5 '-nucleotidase activity due to exposures to adenosine at concentrations from i0-' to 10-' M (Fig. 2) .
We also tested whether CHA and CGS21680C mimic the decreases in ectosolic and cytosolic 5 '-nucleotidase activity seen with exposure to exogenous adenosine. Exposure to CHA decreased ectosolic and cytosolic 5'-nucleotidase activity in rat cardiomyocytes in a dose-dependent manner (Figs. 3 and 4) . In contrast, CGS21680C did not decrease either ectosolic or cytosolic 5'-nucleotidase activity (Fig. 4 ). Third, we tested to see if pertussis toxin, which inhibits Gi proteins, blunts the decrease in ectosolic and cytosolic 5 '-nucleotidase activity due .77 in the adenosine-treated condition with pertussis toxin, P < 0.001 vs. the untreated condition). The treatment with pertussis toxin attenuated the decreases in ectosolic and cytosolic 5 '-nucleotidase activity due to exposure to adenosine concentrations from 10-9 to 10-4 M (Fig. 5) .
We further examined whether the inhibition of synthesis 5 '-nucleotidase are thought to be primarily responsible for the synthesis of adenosine in the heart (1-3), and both enzymes are affected by a number of metabolic factors (20) (21) (22) . Ectosolic 5'-nucleotidase is strongly inhibited by ATP and ADP (20, 21) , whereas cytosolic 5 '-nucleotidase activity is activated by ATP and ADP, and inhibited by inorganic phosphate (22, 23) . This study shows that adenosine inhibits both ectosolic and cytosolic 5 '-nucleotidase. This phenomenon may constitute a negative feedback mechanism or end-product inhibition for adenosine production in cardiomyocytes.
The Al adenosine receptor-mediated signal transduction in the rat cardiomyocytes is necessary to downregulate 5 '-nucleotidase activity. Adenosine is reported to increase the content of inositol 1,4,5-trisphosphate through increases in diacylglycerol (24) , suggesting that protein kinase C may deactivate ectosolic and cytosolic 5 '-nucleotidase. However, we have preliminarily reported that protein kinase C rather activates 5 '-nucleotidase in rat cardiomyocytes (25 5 '-nucleotidase is not the sole determinant of adenosine release. There are two major pathways for adenosine synthesis: The enzymatic dephosphorylation of 5 '-adenosine monophosphate (5'-AMP) by 5'-nucleotidase, and the hydrolysis of Sadenosylhomocysteine hydrolase (27-29). 5 '-Nucleotidase exists in both cellular membrane and cytoplasm, with both being able to produce adenosine (30) (31) (32) . Our study did not establish whether one pathway is more important, and several lines of evidence suggest that both are essential for the production of adenosine in the hypoxic cardiomyocytes (23, [29] [30] [31] [32] .
The activity of adenosine kinase and adenosine deaminase as potential determinants of adenosine production in rat cardiomyocytes also needs to be considered (28). Schrader et al. (31 ) have reported that adenosine kinase contributes to adenosine production in cardiomyocytes. However, the present study does not prove that activation of Gi proteins changes the activity of adenosine kinase and deaminase. This idea needs to be elucidated in further studies.
Pathophysiological relevances in the heart. The finding in this report enhances our understanding of coronary vascular physiology and cardiac pathophysiology. The balance between the amounts of extracellular adenosine acting to produce coronary vasodilation and intracellular adenosine available for ATP synthesis is essential in regulating coronary vascular tone and myocardial metabolism during ischemia and reperfusion. The present results may establish a new regulatory mechanism for myocardial cellular homeostasis in which released adenosine attenuates adenosine production by decreasing 5 '-nucleotidase activity, which in turn spares intracellular adenosine for incorporation into ATP. This finding may explain the interesting observation (33) that norepinephrine infusion increases adenosine release with overshoot, and that adenosine concentration eventually returns to the value between the baseline and the peak values. Decreased 5'-nucleotidase activity secondary to an increase in the adenosine concentration may partially explain this phenomenon.
In summary, our results hint that the relationship between endogenous adenosine and deactivation of 5 '-nucleotidase plays an important role in the switching mechanisms governing storage and release of adenosine for cardioprotection during ischemia.
